Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Assets (2016 - 2025)

Historic Assets for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $12.4 million.

  • Firefly Neuroscience's Assets rose 13360.95% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 13360.95%. This contributed to the annual value of $4.6 million for FY2024, which is 7421.43% up from last year.
  • Per Firefly Neuroscience's latest filing, its Assets stood at $12.4 million for Q3 2025, which was up 13360.95% from $14.9 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Assets ranged from a high of $23.4 million in Q4 2021 and a low of $2.6 million during Q4 2023
  • Its 5-year average for Assets is $9.9 million, with a median of $7.3 million in 2023.
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 51909.1% in 2021, then plummeted by 6901.81% in 2023.
  • Over the past 5 years, Firefly Neuroscience's Assets (Quarter) stood at $23.4 million in 2021, then plummeted by 65.84% to $8.0 million in 2022, then tumbled by 66.91% to $2.6 million in 2023, then surged by 74.21% to $4.6 million in 2024, then skyrocketed by 169.66% to $12.4 million in 2025.
  • Its Assets stands at $12.4 million for Q3 2025, versus $14.9 million for Q2 2025 and $12.4 million for Q1 2025.